Iannone Robert 4
4 · Jazz Pharmaceuticals plc · Filed Jun 7, 2023
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Disposition to Issuer
Ordinary Shares
2023-06-05$129.73/sh−1,311$170,076→ 45,315 total
Footnotes (2)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- [F2]Includes 137 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.